Funding agencies: This study was supported by grants from Novartis Pharmaceuticals (CENA713D US45T; to Joel H. Kramer), the National Institute on Aging (K23AG037566; to Katherine L. Possin), and by the Larry L. Hillblom Foundation (2007/2I; to Bruce L. Miller).
Rivastigmine is associated with restoration of left frontal brain activity in Parkinson's disease
Article first published online: 11 JUL 2013
© 2013 International Parkinson and Movement Disorder Society
Volume 28, Issue 10, pages 1384–1390, September 2013
How to Cite
Possin, K. L., Kang, G. A., Guo, C., Fine, E. M., Trujillo, A. J., Racine, C. A., Wilheim, R., Johnson, E. T., Witt, J. L., Seeley, W. W., Miller, B. L. and Kramer, J. H. (2013), Rivastigmine is associated with restoration of left frontal brain activity in Parkinson's disease. Mov. Disord., 28: 1384–1390. doi: 10.1002/mds.25575
Relevant conflicts of interest/financial disclosures: Nothing to report
- Issue published online: 23 SEP 2013
- Article first published online: 11 JUL 2013
- Manuscript Accepted: 16 MAY 2013
- Manuscript Revised: 29 APR 2013
- Manuscript Received: 11 MAR 2013
Additional Supporting Information may be found in the online version of this article.
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.